American Express Company

(New York Stock Exchange)
Bullish +55

American Express Is Back Near Citi’s $335 Target. What the Forward P/E Says Today’s Price Assumes

📈 AXP shares gained 9% recently, trading near Citi's $335 and Evercore ISI's $330 Hold targets.

📊 The stock trades at a forward P/E of 17x, matching its 10-year average and implying future gains rely on earnings growth.

🚀 American Express raised its Q3 outlook in October, projecting fiscal 2026 normalized EPS between $17.60 and $17.90.

💰 Q3 adjusted EPS reached $4.68 (up 13%) while revenue grew 9%, demonstrating continued margin expansion.

📅 Analysts forecast normalized EPS of $23.21 by fiscal 2028, assuming 13-15% annual growth rates.

🏦 Five major firms updated their ratings in late October, with targets ranging from Citi's $335 to BMO's $380.

📉 The stock is currently down 14% from its 52-week high despite the recent rally.

🔮 Q4 earnings due in late January will provide the first management guidance for fiscal 2027.

⚖️ Current valuation assumes normalized EPS of roughly $20 over the next twelve months with low-to-mid teens growth thereafter.

🛑 A slowdown in card spending or a credit turn would directly impact estimates and cause the price to fall.

Bullish Signals
  • American Express raised its fiscal 2026 EPS outlook to $18.30-$18.60 (adjusted $17.60-$17.90) following a strong Q3 performance.
  • The company delivered 13% adjusted EPS growth and 9% revenue growth in the latest quarter, validating its margin expansion strategy.
  • Analysts project normalized EPS to reach $23.21 by fiscal 2028, implying a solid 15% growth rate in 2028.
  • The stock has rallied 9% in the past month, narrowing the gap to high-end analyst price targets like Morgan Stanley's $380.
Risk Factors
  • The current forward P/E of 17x leaves no discount for investors, meaning future gains must come entirely from earnings growth.
  • The stock is still down 14% from its 52-week high, indicating recent price strength has not yet reached peak valuation levels.
  • Upcoming Q4 results are critical; if they miss consensus or lack 2027 guidance, the stock at an average multiple has little downside support.
Full Analysis
American Express (AXP) shares have rallied 9% over the past month, trading near analyst price targets of $335 from Citi and $330 from Evercore ISI. The stock currently trades at a forward P/E of 17x, which aligns with its 10-year historical average, suggesting that future appreciation depends primarily on earnings growth rather than multiple expansion. Following a Q3 release in October where the company raised its outlook, American Express reported adjusted EPS of $4.68, representing a 13% increase alongside 9% revenue growth. Management now projects fiscal 2026 normalized EPS between $17.60 and $17.90, with consensus estimates settling at $17.82, indicating the current year is largely priced in. Analysts anticipate normalized EPS to reach $23.21 by fiscal 2028, implying growth rates of approximately 13% in 2027 and 15% in 2028. This trajectory assumes revenue grows at a slower 9-10% annual rate, requiring American Express to continue expanding earnings per share faster than its top line to justify current valuations. The stock remains down 14% from its 52-week high, with the next critical test being the Q4 report due in late January. This upcoming release is expected to provide management's first guidance for fiscal 2027, which will be pivotal in validating whether the $380 price targets set by firms like Morgan Stanley and BMO Capital are reasonable.